Investigational Antibiotic Gets Orphan Drug Status for Pulmonary Exacerbations of Cystic Fibrosis MPR, 20 Feb 2020 The Food and Drug Administration has granted Orphan Drug designation to ARV-1801 (sodium fusidate; Arrevus) for the treatment…